Emergent BioSolutions Inc (NYSE:EBS)

33.60
Delayed Data
As of Jul 28
 +0.81 / +2.47%
Today’s Change
19.31
Today|||52-Week Range
34.50
+23.39%
Year-to-Date

Today’s Trading

Previous close32.79
Today’s open33.00
Day’s range-- - --
Volume143,785
Average volume (3 months)254,376
Market cap$1.3B
Dividend yield--
Data as of 07/28/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)+39.45%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio43.7
Price/Sales3.68
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+1.51+4.33%
MGNXMacroGenics Inc+1.79+5.04%
SRPTSarepta Therapeutics...+0.03+0.09%
RGENRepligen Corp+0.55+1.52%
Data as of 07/28/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.11
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers